The Mortality Effect: Counting the Dead in the Cancer Trial

@article{Jain2010TheME,
  title={The Mortality Effect: Counting the Dead in the Cancer Trial},
  author={S Lochlann Jain},
  journal={Public Culture},
  year={2010},
  volume={22},
  pages={89-117}
}
  • S. Jain
  • Published 21 December 2010
  • Medicine
  • Public Culture
In its attempt to recruit patients with late-stage and metastatic renal cancer for a new trial of an experimental cancer treatment, Oxford Biomedica took the standard form of asking and answering an array of imagined patient questions in its patient pamphlet. The trial was organized as a standard randomized control trial (RCT), in which one group of patients would receive the new treatment and the other group would be given the standard treatments. No one would know which group they were in… 

The medicalisation of the dying self: The search for life extension in advanced cancer.

It is proposed that searching for life extension enacts medicalisation by shaping the dying person afflicted with terminal cancer into new medical subjectivities that are knowledgeable, active, entrepreneurial and curative.

Precision patients: Selection practices and moral pathfinding in experimental oncology.

It is argued that silence and non-transparency in interactions between oncologists and patients are crucial to respect the moral agency of patients at the edge of life and recognise them as belonging to the public of Danish health care.

The narrative paradox of the BRCA gene: an ethnographic study in the clinical encounters of ovarian cancer patients

It is argued that a BRCA mutation is not only central to the political economy of hope but takes on a more materialist nature as it becomes an embodied practice that moves in and beyond the clinic.

Surveying risk subjects: Public health surveys as instruments of biomedicalization

It is argued that circumcision-willingness surveys constitute a discursive technology integral to male circumcision’s emergence as an HIV-risk reduction strategy, not simply a tool that identifies willing subjects passively awaiting the next public health intervention.

The sociology of cancer: a decade of research

It is suggested that the understanding of innovations in the fields of cancer research should be extended to take better account of these wider social and cultural innovations, together with patients, activists' and sociologists' contributions therein.

Improvising Medicine: An African Oncology Ward in an Emerging Cancer Epidemic

In Improvising Medicine, Julie Livingston tells the story of Botswana's only dedicated cancer ward, located in its capital city of Gaborone, and describes the cancer ward in terms of the bureaucracy, vulnerability, power, biomedical science, mortality, and hope that shape contemporary experience in southern Africa.

Survival Odds

  • S. Jain
  • Sociology
    Current Anthropology
  • 2011
This article examines the current rhetoric of cancer survivorship in relation to the emergence of new statistical models of cancer incidence, treatment, and mortality record keeping. In this article

Untimely Economies of Survival

This article takes the recent turn against hope in breast cancer activism as a point of entry into a broader examination of speculative economies of science that creatively imagine, materialize, and

The Dialectics of Vulnerability: Breast Cancer and the Body in Prognosis

This essay argues that breast cancer prognosis potentially produces a dialectic in which the subject is compelled to perceive the body as vulnerable and separate (alien) to the self and that the

Evidence-Based Policy: Randomised Controlled Trials’ Knowledge Claims to AIDS Policy

This chapter considers the way in which the Randomised Controlled Trial (RCT) as a policy-relevant knowledge production practice has influenced Global AIDS policy thinking. It unpacks the issue by